Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant cisplatin plus vinorelbine versus observation in high-risk resected stage I non-squamous NSCLC
2013-001494-24Phase 3Completed
- Sponsor
- Encore Clinical Research
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in non-small cell lung cancer (NSCLC) comparing Adjuvant cisplatin plus vinorelbine with Observation (2 arms). Primary endpoint: Overall survival. Started Sep 2013; status: completed.
02
Drugs
cisplatinvinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2013-001494-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001494-24.